Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations

Critically ill patients with COVID-19 are at increased risk for thrombotic complications which has led to an intense debate surrounding their anticoagulation management. In the absence of data from randomized controlled clinical trials, a number of consensus guidelines and recommendations have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Flaczyk, Adam, Rosovsky, Rachel P., Reed, Clay T., Bankhead-Kendall, Brittany K., Bittner, Edward A., Chang, Marvin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492793/
https://www.ncbi.nlm.nih.gov/pubmed/32938471
http://dx.doi.org/10.1186/s13054-020-03273-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492793/
https://www.ncbi.nlm.nih.gov/pubmed/32938471
http://dx.doi.org/10.1186/s13054-020-03273-y

Ejemplares similares